Drug intelligence / Profile preview

Plenum Osshp + injectable platelet-rich fibrin

Development stage
Unknown
Lead developer
Plenum
Administration
Injectable
01

Overview

Plenum Osshp + injectable platelet-rich fibrin is a combination therapy used primarily in regenerative and oral-maxillofacial medicine, notably in bone grafting and sinus elevation procedures[1]. Plenum Osshp is a synthetic or xenogenic bone substitute (details on composition not available in search results) employed as a scaffold to support bone regeneration. Injectable platelet-rich fibrin (i-PRF) is an autologous blood-derived biomaterial made from the patient's own blood, spun to yield a concentrated fraction rich in platelets, leukocytes, cytokines, and growth factors embedded within a fibrin matrix[3][6]. This combination enhances healing by both providing a scaffold (Plenum Osshp) and delivering a sustained release of growth factors and pro-regenerative cytokines (i-PRF)[1][6]. The i-PRF component acts by stimulating angiogenesis, tissue regeneration, reducing inflammation, and supporting stem cell recruitment and differentiation[3][5][6]. This combination is being investigated for accelerating bone and soft tissue regeneration and reducing healing times in surgeries such as maxillary sinus augmentation[1].

Brand names
Plenum Osshp + i-PRF
Other names
injectable platelet-rich fibrini-PRFi-PR
02

Targets

ERBB2 (Erb-b2 receptor tyrosine kinase 2)IGF-1R (Insulin-like growth factor 1 receptor)PDGFRA (Platelet-derived growth factor receptor alpha)VEGFR (VEGFR family)TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on Plenum Osshp + injectable platelet-rich fibrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plenum Osshp + injectable platelet-rich fibrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call